Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
13
ASRT Quote, Financials, Valuation and Earnings
Last price:
$9.33
Seasonality move
:
17.09%
Day range:
$8.61 - $9.25
52-week range:
$7.71 - $15.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.38x
P/B ratio:
0.55x
Volume:
222K
Avg. volume:
44.8K
1-year change:
-30.59%
Market cap:
$58.2M
Revenue:
$125M
EPS (TTM):
-$2.73
Analysts' Opinion
-
Consensus RatingAssertio Holdings, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $39.94, Assertio Holdings, Inc. has an estimated upside of 340.33% from its current price of $9.07.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $24.75 representing -172.88% downside risk from its current price of $9.07.
Fair Value
-
According to the consensus of 3 analysts, Assertio Holdings, Inc. has 340.33% upside to fair value with a price target of $39.94 per share.
ASRT vs. S&P 500
-
Over the past 5 trading days, Assertio Holdings, Inc. has underperformed the S&P 500 by -7.25% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Assertio Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Assertio Holdings, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Assertio Holdings, Inc. reported revenues of $49.5M.
Earnings Growth
-
Assertio Holdings, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Assertio Holdings, Inc. reported earnings per share of $1.61.
Enterprise value:
9.7M
EV / Invested capital:
--
Price / LTM sales:
3.38x
EV / EBIT:
--
EV / Revenue:
0.07x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
0.73x
Price / Operating cash flow:
34.81x
Enterprise value / EBITDA:
0.70x
Gross Profit (TTM):
$62.7M
Return On Assets:
-10.04%
Net Income Margin (TTM):
-21.06%
Return On Equity:
-25.86%
Return On Invested Capital:
-18.41%
Operating Margin:
26.09%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $169.4M | $125.8M | $137.4M | $29.2M | $49.5M | |
| Gross Profit | $115.2M | $64.4M | $62.7M | $14.9M | $30.2M | |
| Operating Income | $45M | -$14.2M | -$16.9M | -$2.7M | $12.9M | |
| EBITDA | $76.7M | $9.8M | $14M | $4M | $18.5M | |
| Diluted EPS | -$2.05 | -$0.72 | -$2.73 | -$0.03 | $1.61 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $112.5M | $126.5M | $185M | $181.2M | $263.6M | |
| Total Assets | $299.3M | $323.3M | $380M | $276M | $319.8M | |
| Current Liabilities | $100.5M | $92.3M | $109.9M | $90.1M | $166.8M | |
| Total Liabilities | $202.4M | $188.4M | $187.2M | $145.5M | $214M | |
| Total Equity | $96.9M | $134.9M | $192.9M | $130.5M | $105.8M | |
| Total Debt | $79.4M | $68.3M | $40.5M | $49.2M | $44.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $70.6M | $20.6M | $13.3M | -$35K | -$4.8M | |
| Cash From Investing | -$22.4M | -$50.3M | -$12.6M | -$6.7M | -$3.8M | |
| Cash From Financing | -$36.1M | -$9.2M | -$246K | -$10K | -$7K | |
| Free Cash Flow | $86.4M | $20.7M | $13.3M | -$35K | -$4.8M | |
ASRT
Sector
Market Cap
$58.2M
$28.1M
Price % of 52-Week High
59.87%
50%
Dividend Yield
0%
0%
Shareholder Yield
-1.02%
-1.54%
1-Year Price Total Return
-30.59%
-17.67%
Beta (5-Year)
0.615
0.503
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$9.91
200-day SMA
Sell
Level
$10.98
Bollinger Bands (100)
Sell
Level
10.88 - 13.06
Chaikin Money Flow
Sell
Level
-5.1M
20-day SMA
Sell
Level
$10.83
Relative Strength Index (RSI14)
Sell
Level
26.24
ADX Line
Sell
Level
26.47
Williams %R
Buy
Level
-86.4304
50-day SMA
Sell
Level
$11.30
MACD (12, 26)
Sell
Level
-0.58
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
4.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.3911)
Sell
CA Score
(Annual)
Level (-0.7732)
Buy
Beneish M-Score
(Annual)
Level (-8.0658)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (8.8499)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Stock Forecast FAQ
In the current month, ASRT has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ASRT average analyst price target in the past 3 months is $39.94.
-
Where Will Assertio Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Assertio Holdings, Inc. share price will rise to $39.94 per share over the next 12 months.
-
What Do Analysts Say About Assertio Holdings, Inc.?
Analysts are divided on their view about Assertio Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Assertio Holdings, Inc. is a Sell and believe this share price will drop from its current level to $24.75.
-
What Is Assertio Holdings, Inc.'s Price Target?
The price target for Assertio Holdings, Inc. over the next 1-year time period is forecast to be $39.94 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ASRT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Assertio Holdings, Inc. is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ASRT?
You can purchase shares of Assertio Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Assertio Holdings, Inc. shares.
-
What Is The Assertio Holdings, Inc. Share Price Today?
Assertio Holdings, Inc. was last trading at $9.33 per share. This represents the most recent stock quote for Assertio Holdings, Inc.. Yesterday, Assertio Holdings, Inc. closed at $9.07 per share.
-
How To Buy Assertio Holdings, Inc. Stock Online?
In order to purchase Assertio Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ASRT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ASRT
Sector
P/E ratio
--
23.88x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.55x
1.82x
Price / LTM sales
3.38x
1.59x
Growth Metrics
ASRT
Sector
Revenue growth
69.36%
4.73%
Earnings growth
5367.32%
11.11%
Revenue (5-year growth)
-11.45%
6.46%
Earnings forecast
-$1.80
-$0.18
Profitability
ASRT
Sector
Profitability FY 2024
$59.9M
$3.6M
Return on invested capital
-18.41%
-31.77%
Return on assets
-10.04%
-28.18%
Return on equity
-25.86%
-37.47%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
9
Estimated Next Earnings Date
Feb
9
Balance Sheet
ASRT
Sector
Total cash
$93.4M
$26.3M
Short term investments
$49.5M
$26M
Total assets
$284.7M
$76.9M
Long term debt
$44.7M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 6.72% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 2.43% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 6.14% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
